Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Revenue

Samil Pharmaceutical Co.,Ltd had revenue of 53.32B KRW in the quarter ending September 30, 2024, with 3.28% growth. This brings the company's revenue in the last twelve months to 212.42B, up 12.22% year-over-year. In the year 2023, Samil Pharmaceutical Co.,Ltd had annual revenue of 196.35B with 9.28% growth.

• Revenue (ttm): 212.42B
• Revenue Growth: +12.22%
• P/S Ratio: 0.97
• Revenue / Employee: 363.12M
• Employees: 585
• Market Cap: 261.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%
Dec 31, 2020	123.00B	1.89B	1.56%
Dec 31, 2019	121.11B	26.51B	28.02%